Verisante Technology Inc
Verisante Technology Inc. does not have significant operations. Previously, the company was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was incorporated in 2006 and is based in Vancouver, Canada.
Verisante Technology Inc (VRSEF) - Total Assets
Latest total assets as of September 2025: $5.61K USD
Based on the latest financial reports, Verisante Technology Inc (VRSEF) holds total assets worth $5.61K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Verisante Technology Inc - Total Assets Trend (2008–2024)
This chart illustrates how Verisante Technology Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Verisante Technology Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Verisante Technology Inc's total assets of $5.61K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 64.6% |
| Accounts Receivable | $2.92K | 24.8% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how Verisante Technology Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Verisante Technology Inc's current assets represent 100.0% of total assets in 2024, an increase from 66.0% in 2008.
- Cash Position: Cash and equivalents constituted 64.6% of total assets in 2024, up from 42.2% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 27.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 24.8% of total assets.
Verisante Technology Inc Competitors by Total Assets
Key competitors of Verisante Technology Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Verisante Technology Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Verisante Technology Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Verisante Technology Inc is currently not profitable relative to its asset base.
Verisante Technology Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.18 | 1.04 | 0.54 |
| Quick Ratio | 0.18 | 1.04 | 0.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-26.23K | $ 360.00 | $ -1.01 Million |
Verisante Technology Inc - Advanced Valuation Insights
This section examines the relationship between Verisante Technology Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 24.22 |
| Latest Market Cap to Assets Ratio | 4.47 |
| Asset Growth Rate (YoY) | -67.1% |
| Total Assets | $11.77K |
| Market Capitalization | $52.59K USD |
Valuation Analysis
Premium Asset Valuation: The market values Verisante Technology Inc's assets at a significant premium ( 4.47x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Verisante Technology Inc's assets decreased by 67.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Verisante Technology Inc (2008–2024)
The table below shows the annual total assets of Verisante Technology Inc from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $11.77K | -67.07% |
| 2023-12-31 | $35.73K | -59.55% |
| 2022-12-31 | $88.33K | -39.48% |
| 2021-12-31 | $145.94K | +1101.69% |
| 2020-12-31 | $12.14K | +5.49% |
| 2019-12-31 | $11.51K | -96.46% |
| 2018-12-31 | $324.91K | -0.90% |
| 2017-12-31 | $327.85K | -85.92% |
| 2016-12-31 | $2.33 Million | -30.86% |
| 2015-12-31 | $3.37 Million | -28.61% |
| 2014-12-31 | $4.72 Million | -13.25% |
| 2013-12-31 | $5.44 Million | -20.33% |
| 2012-12-31 | $6.83 Million | -22.08% |
| 2011-12-31 | $8.76 Million | +473.80% |
| 2010-12-31 | $1.53 Million | +6.70% |
| 2009-12-31 | $1.43 Million | +524.26% |
| 2008-12-31 | $229.22K | -- |